Duke Pathology Well Represented at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting
Duke Pathology had a strong presence at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in San Antonio, Texas, from March 21-26, 2026.
From Biopsy to Breakthrough: Duke Students Dive into the Diagnostic Process
On March 11, 2026, the Duke Pathology Interest Group hosted “How is a Diagnosis REALLY made?
New Ranking Highlights NIH’s Impact on Breakthrough Science at Duke Pathology
Duke Pathology received more than $13 million in research funding from the National Institutes of Health (NIH) in 2025, with Duke University School of Medicine r
Dr. John Toffaletti Co-Authors Landmark Study Showing How Shunt Valve Equations are Calculated
Duke Pathology Professor John Toffaletti, PhD, co‑authored a study titled
From Brain Tissue to Blood Tests: Dr. Shih-Hsiu "Jerry" Wang's Research Featured as Translational Science Case Study
Given recent successful developments in treatment for early-stage Alzheimer’s disease, there is a need for tests that allow early diagnosis and prognosis assessment. Duke Pathology's Shih-Hsiu “Jerry” Wang, MD, PhD, and NCCU's Bin Xu, PhD, partnered to conduct research to develop minimally invasive tests for earlier disease diagnosis and monitoring severity
Duke Pathology Faculty Members and Trainees Serve as Editors and Authors of Upcoming Mesothelioma Book
Duke Pathology’s Elizabeth N.